Picard Medical Completes Successful IPO Raising $17 Million

An announcement from Picard Medical, Inc. ( (PMI) ) is now available.

Picard Medical, Inc. completed its initial public offering (IPO) on September 2, 2025, offering 4,250,000 shares at $4.00 each, raising $17 million. The company plans to use the proceeds to expand its market presence, particularly through a joint venture in China, and to fund research and development for new products. The IPO marks a significant step in Picard Medical’s growth strategy, potentially enhancing its industry positioning and operational capabilities.

More about Picard Medical, Inc.

Picard Medical, Inc. is a medical technology company based in Tucson, Arizona, and is the parent company of SynCardia Systems, LLC. It specializes in developing, manufacturing, and commercializing the SynCardia Total Artificial Heart (STAH), which is the only FDA and Health Canada-approved total artificial heart available in the U.S. and Canada. The company focuses on providing solutions for patients with end-stage heart failure and has performed over 2,100 implants across 27 countries.

Average Trading Volume: 4,347,438

For an in-depth examination of PMI stock, go to TipRanks’ Overview page.